Your browser version may not work well with NCBI's Web applications. More information here...
1: Nat Immunol. 2008 Jan;9(1):73-80. Epub 2007 Nov 18.
Related Articles, Links
Click here to read Click here to read Click here to read
Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13.

Bansal G, Xie Z, Rao S, Nocka KH, Druey KM.

Molecular Signal Transduction Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.

Mast cells elicit allergic responses through degranulation and release of proinflammatory mediators after antigen crosslinking of the immunoglobulin E receptor FcepsilonRI. Proteins of the 'regulator of G protein signaling' (RGS) family negatively control signaling mediated by G protein-coupled receptors through GTPase-accelerating protein activity. Here we show that RGS13 inhibited allergic responses by physically interacting with the regulatory p85alpha subunit of phosphatidylinositol-3-OH kinase in mast cells and disrupting its association with an FcepsilonRI-activated scaffolding complex. Rgs13-/- mice had enhanced immunoglobulin E-mediated mast cell degranulation and anaphylaxis. Thus, RGS13 inhibits the assembly of immune receptor-induced signalosomes in mast cells. Abnormal RGS13 expression or function may contribute to disorders of amplified mast cell activity, such as idiopathic anaphylaxis.

Publication Types:
PMID: 18026105 [PubMed - indexed for MEDLINE]

PMCID: PMC2387203